BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 36999064)

  • 1. Heparin-based versus bivalirudin-based anticoagulation in pediatric extracorporeal membrane oxygenation: A systematic review.
    Valdes CA; Sharaf OM; Bleiweis MS; Jacobs JP; Mumtaz M; Sharaf RM; Jeng EI; Peek GJ
    Front Med (Lausanne); 2023; 10():1137134. PubMed ID: 36999064
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bivalirudin versus heparin anticoagulation in patients receiving extracorporeal membrane oxygenation.
    Huang D; Guan Q; Qin J; Shan R; Wu J; Zhang C
    Perfusion; 2023 Sep; 38(6):1133-1141. PubMed ID: 35616224
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is bivalirudin an alternative anticoagulant for extracorporeal membrane oxygenation (ECMO) patients? A systematic review and meta-analysis.
    Li DH; Sun MW; Zhang JC; Zhang C; Deng L; Jiang H
    Thromb Res; 2022 Feb; 210():53-62. PubMed ID: 35007937
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of bivalirudin versus heparin in adult extracorporeal membrane oxygenation anticoagulant therapy: A retrospective case-control study.
    Tong Y; Rouzhahong J; Zhou W; Wang R; Wang Y; Ren Y; Guo J; Li Y; Wang Z; Song Y
    Int J Artif Organs; 2023 Mar; 46(3):162-170. PubMed ID: 36600413
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of bivalirudin for anticoagulation in pediatric extracorporeal membrane oxygenation (ECMO).
    Kaushik S; Derespina KR; Chandhoke S; Shah DD; Cohen T; Shlomovich M; Medar SS; Peek GJ
    Perfusion; 2023 Jan; 38(1):58-65. PubMed ID: 34318718
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of Bivalirudin As an Alternative to Heparin for Systemic Anticoagulation in Pediatric Extracorporeal Membrane Oxygenation.
    Hamzah M; Jarden AM; Ezetendu C; Stewart R
    Pediatr Crit Care Med; 2020 Sep; 21(9):827-834. PubMed ID: 32404633
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of Bivalirudin Anticoagulation Therapy for Extracorporeal Membrane Oxygenation in Heparin-Induced Thrombocytopenia: A Case Report and a Systematic Review.
    Zhong H; Zhu ML; Yu YT; Li W; Xing SP; Zhao XY; Wang WJ; Gu ZC; Gao Y
    Front Pharmacol; 2020; 11():565013. PubMed ID: 33013402
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Efficacy and Safety of Bivalirudin Versus Heparin in the Anticoagulation Therapy of Extracorporeal Membrane Oxygenation: A Systematic Review and Meta-Analysis.
    Ma M; Liang S; Zhu J; Dai M; Jia Z; Huang H; He Y
    Front Pharmacol; 2022; 13():771563. PubMed ID: 35496287
    [No Abstract]   [Full Text] [Related]  

  • 9. Superiority of bivalirudin over heparin anticoagulation therapy for extracorporeal membrane oxygenation? Too early to draw conclusions.
    Gu J; Yu H; Lin D
    Heliyon; 2023 Feb; 9(2):e13530. PubMed ID: 36865472
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extracorporeal Membrane Oxygenation Complications in Heparin- and Bivalirudin-Treated Patients.
    Giuliano K; Bigelow BF; Etchill EW; Velez AK; Ong CS; Choi CW; Bush E; Cho SM; Whitman GJR
    Crit Care Explor; 2021 Jul; 3(7):e0485. PubMed ID: 34278315
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of Bivalirudin Versus Heparin for Maintenance Systemic Anticoagulation During Adult and Pediatric Extracorporeal Membrane Oxygenation.
    Seelhammer TG; Bohman JK; Schulte PJ; Hanson AC; Aganga DO
    Crit Care Med; 2021 Sep; 49(9):1481-1492. PubMed ID: 33870916
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of bleeding and thrombotic outcomes in veno-venous extracorporeal membrane oxygenation: Heparin versus bivalirudin.
    Kartika T; Mathews R; Migneco G; Bundy T; Kaempf AJ; Pfeffer M; DeLoughery TG; Moore K; Beardshear R; Oetken HJ; Case J; Hinds MT; McCarty OJT; Shatzel JJ; Zonies D; Zakhary B
    Eur J Haematol; 2024 Apr; 112(4):566-576. PubMed ID: 38088062
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heparin Versus Bivalirudin for Anticoagulation in Adult Extracorporeal Membrane Oxygenation: A Systematic Review and Meta-Analysis.
    Wieruszewski PM; Macielak SA; Nei SD; Moman RN; Seelhammer TG; Nabzdyk CGS; Gerberi DJ; Mara KC; Hooten WM; Wittwer ED
    ASAIO J; 2023 Feb; 69(2):137-144. PubMed ID: 36355803
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of Wholesale Drug Acquisition and Laboratory Assessment Costs Between Heparin Compared With Bivalirudin-Based Systemic Anticoagulation Strategies in Adult Extracorporeal Membrane Oxygenation.
    Seelhammer TG; Brokmeier HM; Hamzah M; Wieruszewski PM
    Crit Care Med; 2023 May; 51(5):e115-e121. PubMed ID: 36853326
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bivalirudin or heparin for systemic anticoagulation during pediatric extracorporeal membrane oxygenation: Multicenter retrospective study.
    Hamzah M; Seelhammer TG; Beshish AG; Byrnes J; Yabrodi M; Szadkowski A; Lutfi R; Andrijasevic N; Hock K; Worley S; Macrae DJ
    Thromb Res; 2023 Sep; 229():178-186. PubMed ID: 37517208
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bivalirudin-based versus conventional heparin anticoagulation for postcardiotomy extracorporeal membrane oxygenation.
    Ranucci M; Ballotta A; Kandil H; Isgrò G; Carlucci C; Baryshnikova E; Pistuddi V;
    Crit Care; 2011; 15(6):R275. PubMed ID: 22099212
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of clinical outcomes in patients treated with heparin or direct thrombin inhibitors during extracorporeal membrane oxygenation: a systematic review and meta-analysis.
    M'Pembele R; Roth S; Metzger A; Nucaro A; Stroda A; Polzin A; Hollmann MW; Lurati Buse G; Huhn R
    Thromb J; 2022 Jul; 20(1):42. PubMed ID: 35902857
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of anticoagulation with bivalirudin for heparin-induced thrombocytopenia during extracorporeal membrane oxygenation.
    Hanna DJ; Torbic H; Militello M; Strnad K; Krishnan S; Hohlfelder B
    Int J Artif Organs; 2022 Aug; 45(8):688-694. PubMed ID: 35708334
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anticoagulation strategies in COVID-19 infected patients receiving ECMO support.
    Diaz D; Martinez J; Bushman G; Wolowich WR
    J Extra Corpor Technol; 2023 Sep; 55(3):121-129. PubMed ID: 37682210
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of Systemic Heparin Versus Bivalirudin in Adult Patients Supported by Extracorporeal Membrane Oxygenation.
    Berei TJ; Lillyblad MP; Wilson KJ; Garberich RF; Hryniewicz KM
    ASAIO J; 2018; 64(5):623-629. PubMed ID: 29076942
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.